nderstanding determinants of treatment response in first-episode schizophrenia
Not Applicable
- Conditions
- Health Condition 1: F20-F29- Schizophrenia, schizotypal, delusional, and other non-mood psychotic disorders
- Registration Number
- CTRI/2023/01/049256
- Lead Sponsor
- STEP Program supported by the Gustavus and Louise Pfeiffer Research Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Participants will be approached for recruitment in this study if they have a diagnosis of schizophrenia or schizophreniform disorder based on the DSM-5 guidelines, as diagnosed by two trained psychiatrists and confirmed using the SCID-5-CV. Other selection criteria include a duration of illness of < 5 years, age > 13 years, any gender, antipsychotic naïve (never prescribed antipsychotics) or antipsychotic free (off antipsychotics for >2 months)
Exclusion Criteria
Pregnant or post-partum state, clinically discernible neurological disorders or visual and hearing impairment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method